These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 11076532)

  • 1. The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors.
    Xu W; Chen C; Huang P; Li J; de Riel JK; Javitch JA; Liu-Chen LY
    Biochemistry; 2000 Nov; 39(45):13904-15. PubMed ID: 11076532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors.
    Xu W; Li J; Chen C; Huang P; Weinstein H; Javitch JA; Shi L; de Riel JK; Liu-Chen LY
    Biochemistry; 2001 Jul; 40(27):8018-29. PubMed ID: 11434771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The seventh transmembrane domains of the delta and kappa opioid receptors have different accessibility patterns and interhelical interactions.
    Xu W; Campillo M; Pardo L; Kim de Riel J; Liu-Chen LY
    Biochemistry; 2005 Dec; 44(49):16014-25. PubMed ID: 16331961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selected cysteine residues in transmembrane domains of mu-opioid receptor are critical for effects of sulfhydryl reagents.
    Deng HB; Guang W; Wang JB
    J Pharmacol Exp Ther; 2000 Apr; 293(1):113-20. PubMed ID: 10734160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the mu opioid receptor involves conformational rearrangements of multiple transmembrane domains.
    Xu W; Sanz A; Pardo L; Liu-Chen LY
    Biochemistry; 2008 Oct; 47(40):10576-86. PubMed ID: 18778083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine 2.59(89) in the second transmembrane domain of human CB2 receptor is accessible within the ligand binding crevice: evidence for possible CB2 deviation from a rhodopsin template.
    Zhang R; Hurst DP; Barnett-Norris J; Reggio PH; Song ZH
    Mol Pharmacol; 2005 Jul; 68(1):69-83. PubMed ID: 15840841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the "address" recognition locus.
    Metzger TG; Paterlini MG; Ferguson DM; Portoghese PS
    J Med Chem; 2001 Mar; 44(6):857-62. PubMed ID: 11300867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the proximity of the extreme N-terminus of the neurokinin-2 (NK2) tachykinin receptor to Cys167 in the putative fourth transmembrane helix.
    Bhogal N; Blaney FE; Ingley PM; Rees J; Findlay JB
    Biochemistry; 2004 Mar; 43(11):3027-38. PubMed ID: 15023054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.
    Wang WW; Shahrestanifar M; Jin J; Howells RD
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12436-40. PubMed ID: 8618916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.
    Hirota K; Okawa H; Appadu BL; Grandy DK; Devi LA; Lambert DG
    Anesthesiology; 1999 Jan; 90(1):174-82. PubMed ID: 9915326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.
    Pogozheva ID; Lomize AL; Mosberg HI
    Biophys J; 1998 Aug; 75(2):612-34. PubMed ID: 9675164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel structural determinants of mu-conotoxin (GIIIB) block in rat skeletal muscle (mu1) Na+ channels.
    Li RA; Ennis IL; Vélez P; Tomaselli GF; Marbán E
    J Biol Chem; 2000 Sep; 275(36):27551-8. PubMed ID: 10859326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmembrane domain VII of the human apical sodium-dependent bile acid transporter ASBT (SLC10A2) lines the substrate translocation pathway.
    Hussainzada N; Banerjee A; Swaan PW
    Mol Pharmacol; 2006 Nov; 70(5):1565-74. PubMed ID: 16899538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors.
    Chen Y; Mestek A; Liu J; Yu L
    Biochem J; 1993 Nov; 295 ( Pt 3)(Pt 3):625-8. PubMed ID: 8240267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of opioid receptor binding to N-substituted maleimides and methanethiosulfonate derivatives.
    Shahrestanifar MS; Howells RD
    Neurochem Res; 1996 Nov; 21(11):1295-9. PubMed ID: 8947919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the rat.
    Richards ML; Sadée W
    J Pharmacol Exp Ther; 1985 May; 233(2):425-32. PubMed ID: 2987482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General, kappa, delta and mu opioid receptor antagonists mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions.
    Miner P; Shimonova L; Khaimov A; Borukhova Y; Ilyayeva E; Ranaldi R; Bodnar RJ
    Brain Res; 2012 Mar; 1443():34-51. PubMed ID: 22305145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of gamma-hydroxybutyrate on mu, delta and kappa opioid receptor binding.
    Feigenbaum JJ; Simantov R
    Neurosci Lett; 1996 Jul; 212(1):5-8. PubMed ID: 8823749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible binding of cis-(+)-3-methylfentanyl isothiocyanate to the delta opioid receptor and determination of its binding domain.
    Zhu J; Yin J; Law PY; Claude PA; Rice KC; Evans CJ; Chen C; Yu L; Liu-Chen LY
    J Biol Chem; 1996 Jan; 271(3):1430-4. PubMed ID: 8576134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.